Urolithin A Supplementation to Boost Immune Health

Inclusion criteria

Healthy Adults that do not suffer from an uncontrolled chronic medical condition that carries metabolic consequences (as assessed by the study physician)

• BMI<35kg/m2
• Provide informed consent
• Adults aged 45-70 years, both genders
• Subjects who have not received any systemic immunosuppression in the past 6 months
• Subjects with any medical condition that in the opinion of the investigators would compromise the study outcome or the safety of the research participant

Exclusion criteria

Subject has any concurrent medical, orthopedic, or psychiatric condition that, in the opinion of the Investigator, would compromise his/her ability to comply with the study requirements;

• Clinically significant abnormal laboratory results at screening
• Participation in a clinical research trial within 30 days prior to randomization
• Allergy or sensitivity to study ingredients
• Individuals who are cognitively impaired and/or who are unable to give informed consent
• Any condition which in the Investigator's opinion may adversely affect the subject's ability to complete the study or its measures or which may pose significant risk to the subject
• Current gastrointestinal condition which could interfere with the study (e.g. IBS/IBD, diarrhea, acid reflux disease, dysphagia etc.);
• Excessive alcohol consumption and/or a smoker
• Concomitant use of statins
• Engage in regular moderate or vigorous physically activities (i.e. Category 3 as per the IPAQ activity classification)
• Concomitant use of corticosteroids, antibiotics, any anabolic steroid, creatine, whey protein supplements, casein or branched-chain amino acids (BCAAs), immune-boosting(Vitamin C, Zinc) or mitochondrial (COQ10, NAD+) supplements within 45 days prior to screening